tion. These results strongly suggested that our evaluation of bla CTX-M-14 location in the examined E. coli isolates was appropriately performed. No statistical significance was observed by the 2 test among isolate group, phylogenetic group, location of bla CTX-M-14 , and prevalence of chromosomal bla CTX-M-14 .
Susceptibility of the E. coli isolates examined to amikacin (AMK), gentamicin (GEN), ciprofloxacin (CIP), norfloxacin (NOR), tetracycline (TET), imipenem (IPM), and meropenem (MEM) was also examined. Antibiotic resistance profiles of the JO and the KC isolates were not noticeably different among each of the isolate groups, regardless of bla CTX-M-14 location.
Our results showed that 46 of the 74 examined isolates (62.2%) possessed at least one copy of chromosomal bla CTX-M-14 . In this study, we could not determine all sequences surrounding chromosomal bla CTX-M-14 in the E. coli isolates possessing chromosomal bla CTX-M-14 . In addition, the copy number and stability of chromosomal bla CTX-M-14 in the E. coli isolates remain unclear. Nevertheless, taking into account that the chromosomal location of bla CTX-M-14 transposition units was detected even in the KC isolates from asymptomatic healthy individuals living in a rural area in Thailand, the chromosomal location of the bla CTX-M-14 transposition unit might be one factor contributing to the worldwide spread of E. coli strains producing CTX-M-14-type ESBL.
